Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
342
datasets available to search
ShareScore release 0.9.0
Dataset results
342 results for “Biliary tract”
Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT06282120. IPD Sharing: NO. Countries: 1. Publications: 0.
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
ClinicalTrials.gov study NCT03801083. IPD Sharing: NO. Countries: 1. Publications: 0.
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas
ClinicalTrials.gov study NCT05482893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer
ClinicalTrials.gov study NCT04608786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
ClinicalTrials.gov study NCT06001658. IPD Sharing: NO. Countries: 1. Publications: 0.
Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT03231176. IPD Sharing: NO. Countries: 1. Publications: 0.
GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）
ClinicalTrials.gov study NCT06988592. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00504192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma
ClinicalTrials.gov study NCT03830606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
ClinicalTrials.gov study NCT04611867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
ClinicalTrials.gov study NCT06280508. IPD Sharing: NO. Countries: 1. Publications: 0.
Diagnosis and Percutaneous Treatment of Biliary Tract Diseases
ClinicalTrials.gov study NCT06816615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05429697. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
ClinicalTrials.gov study NCT05849480. IPD Sharing: YES. Countries: 1. Publications: 0.
XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
ClinicalTrials.gov study NCT02350686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Questionnaire Survey for Biliary Tract Cancers
ClinicalTrials.gov study NCT04731220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma
ClinicalTrials.gov study NCT06199882. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)
ClinicalTrials.gov study NCT05823987. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer
ClinicalTrials.gov study NCT03440450. IPD Sharing: NO. Countries: 1. Publications: 0.
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
ClinicalTrials.gov study NCT03482102. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.